Lamotrigine-induced obsessional symptoms in a patient with bipolar II disorder: a case report. 2009

M Kuloglu, and A Caykoylu, and O Ekinci, and E Yilmaz
Department of Psychiatry, Ataturk Education and Research Hospital, Ankara, Turkey. kuloglum@yahoo.com

Lamotrigine is an anticonvulsant that appears to have a mainly antidepressant effect and is indicated for the maintenance treatment of bipolar depression. Literature associated with obsessional symptoms related to lamotrigine treatment is limited. We report the emergence of obsessive symptoms during treatment with lamotrigine in a patient who subsequently experienced significant improvement after dose reduction and stopping of this medication. The obsessive symptoms associated with lamotrigine treatment were observed after the lamotrigine dose was increased to 100 mg/day. The possible mechanisms, including inhibition on the presynaptic release of glutamate and alteration of striatal dopamine uptake, are discussed. It is unclear why lamotrigine induces obsessions in some patients. Controlled studies are necessary to identify the population at risk for obsessionality in bipolar illness following treatment with lamotrigine and to investigate a possible dose-response relationship between obsessive symptoms and lamotrigine.

UI MeSH Term Description Entries
D009770 Obsessive Behavior Persistent, unwanted idea or impulse which is considered normal when it does not markedly interfere with mental processes or emotional adjustment. Obsessions,Behavior, Obsessive,Behaviors, Obsessive,Obsession,Obsessive Behaviors
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000077213 Lamotrigine A phenyltriazine compound, sodium and calcium channel blocker that is used for the treatment of SEIZURES and BIPOLAR DISORDER. 3,5-Diamino-6-(2,3-dichlorophenyl)-1,2,4-triazine,3,5-Diamino-6-(2,3-dichlorophenyl)-as-triazine,BW-430C,Crisomet,Labileno,Lamictal,Lamiktal,BW 430C,BW430C
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000927 Anticonvulsants Drugs used to prevent SEIZURES or reduce their severity. Anticonvulsant,Anticonvulsant Drug,Anticonvulsive Agent,Anticonvulsive Drug,Antiepileptic,Antiepileptic Agent,Antiepileptic Agents,Antiepileptic Drug,Anticonvulsant Drugs,Anticonvulsive Agents,Anticonvulsive Drugs,Antiepileptic Drugs,Antiepileptics,Agent, Anticonvulsive,Agent, Antiepileptic,Agents, Anticonvulsive,Agents, Antiepileptic,Drug, Anticonvulsant,Drug, Anticonvulsive,Drug, Antiepileptic,Drugs, Anticonvulsant,Drugs, Anticonvulsive,Drugs, Antiepileptic
D001714 Bipolar Disorder A major affective disorder marked by severe mood swings (manic or major depressive episodes) and a tendency to remission and recurrence. Affective Psychosis, Bipolar,Bipolar Disorder Type 1,Bipolar Disorder Type 2,Bipolar Mood Disorder,Depression, Bipolar,Manic Depression,Manic Disorder,Manic-Depressive Psychosis,Psychosis, Manic-Depressive,Type 1 Bipolar Disorder,Type 2 Bipolar Disorder,Psychoses, Manic-Depressive,Bipolar Affective Psychosis,Bipolar Depression,Bipolar Disorders,Bipolar Mood Disorders,Depression, Manic,Depressions, Manic,Disorder, Bipolar,Disorder, Bipolar Mood,Disorder, Manic,Manic Depressive Psychosis,Manic Disorders,Mood Disorder, Bipolar,Psychoses, Bipolar Affective,Psychoses, Manic Depressive,Psychosis, Bipolar Affective,Psychosis, Manic Depressive
D014227 Triazines Heterocyclic rings containing three nitrogen atoms, commonly in 1,2,4 or 1,3,5 or 2,4,6 formats. Some are used as HERBICIDES. Triazine,Benzotriazines

Related Publications

M Kuloglu, and A Caykoylu, and O Ekinci, and E Yilmaz
June 2002, Psychopharmacology,
M Kuloglu, and A Caykoylu, and O Ekinci, and E Yilmaz
October 2013, Journal of child and adolescent psychopharmacology,
M Kuloglu, and A Caykoylu, and O Ekinci, and E Yilmaz
January 2003, Actas espanolas de psiquiatria,
M Kuloglu, and A Caykoylu, and O Ekinci, and E Yilmaz
December 2018, Journal of the Formosan Medical Association = Taiwan yi zhi,
M Kuloglu, and A Caykoylu, and O Ekinci, and E Yilmaz
August 2019, CNS spectrums,
M Kuloglu, and A Caykoylu, and O Ekinci, and E Yilmaz
January 2006, The American journal of psychiatry,
M Kuloglu, and A Caykoylu, and O Ekinci, and E Yilmaz
May 2017, Actas espanolas de psiquiatria,
M Kuloglu, and A Caykoylu, and O Ekinci, and E Yilmaz
October 2021, Industrial psychiatry journal,
M Kuloglu, and A Caykoylu, and O Ekinci, and E Yilmaz
March 2020, Brain sciences,
M Kuloglu, and A Caykoylu, and O Ekinci, and E Yilmaz
January 2017, The Journal of clinical psychiatry,
Copied contents to your clipboard!